Marhofer John A Jr 4
4 · CLEVELAND BIOLABS INC · Filed Mar 22, 2011
Insider Transaction Report
Form 4
Marhofer John A Jr
Chief Financial Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-03-21+149,609→ 149,609 totalExercise: $7.16From: 2011-03-21Exp: 2021-03-20→ Common Stock (149,609 underlying)
Holdings
- 105,000
Employee Stock Options (Right to Buy)
Exercise: $3.44From: 2010-05-18Exp: 2020-05-17→ Common Stock (105,000 underlying) - 23,184
Employee Stock Options (Right to Buy)
Exercise: $0.67From: 2005-07-01Exp: 2015-06-30→ Common Stock (23,184 underlying) - 20,000
Employee Stock Options (Right to Buy)
Exercise: $4.50From: 2006-03-01Exp: 2016-02-28→ Common Stock (20,000 underlying) - 25,000
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (25,000 underlying) - 91,500
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (91,500 underlying)
Footnotes (1)
- [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Marhofer per the 2010 Executive Compensation Plan.